Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
35,258,614
-
Total 13F shares
-
3,647,399
-
Share change
-
-74,445
-
Total reported value
-
$11,674,122
-
Put/Call ratio
-
3.1%
-
Price per share
-
$3.20
-
Number of holders
-
45
-
Value change
-
-$399,198
-
Number of buys
-
15
-
Number of sells
-
14
Institutional Holders of Anixa Biosciences Inc - Common Stock (ANIX) as of Q2 2023
As of 30 Jun 2023,
Anixa Biosciences Inc - Common Stock (ANIX) was held by
45 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,647,399 shares.
The largest 10 holders included
VANGUARD GROUP INC, UBS Group AG, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., Long Focus Capital Management, LLC, STATE STREET CORP, Bank of New York Mellon Corp, RENAISSANCE TECHNOLOGIES LLC, RAYMOND JAMES & ASSOCIATES, and NORTHERN TRUST CORP.
This page lists
45
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.